Navigation Links


deficit in Biological Technology

Spectral announces first quarter 2009 results

... 5,716 5,716 deficit ... Statements of Operations, Comprehensive Loss and deficit - unaudited For the three months ended March ... for the period (404) (448) deficit - Beginning of period ...

Spectral announces 2008 financial results

... 5,716 5,606 deficit ... the year (1,502) (1,666) deficit - Beginning of year (2,687) ... ---------------------------- deficit - End of year (4,189) ...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

... VYVANSE - for use in the treatment of attention deficit and hyperactivity disorder ("ADHD") in children ... Shire focuses its business on attention deficit and hyperactivity disorder ("ADHD"), human ... 97.0 55.7 Accumulated deficit (1,051.7) ...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

... 511,866 502,163 Accumulated deficit (642,053) (576,501) Total stockholders' deficit (130,187) (74,338) Total liabilities and stockholders' deficit $263,002 $183,050 ...

Spectral announces third quarter 2008 results

... 5,671 5,606 deficit ... Statements of Operations, Comprehensive Loss and deficit - unaudited For the nine months ended September ... (332) (382) (1,199) (968) deficit - Beginning of period ...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... (lisdexamfetamine dimesylate) - Attention deficit and Hyperactivity Disorder ("ADHD") - The ... (lisdexamfetamine dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ... 85.6 55.7 Accumulated deficit (1,115.1) ...

Monogram Announces 2008 Third Quarter Financial Results

... $69,311 LIABILITIES AND STOCKHOLDERS' deficit Current liabilities: Accounts payable ... - (31) Accumulated deficit (299,714) (287,539) Total stockholders' deficit (8,945) (1,240) ...

Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program

... ADHD Experts to Answer Questions about Attention deficit Hyperactivity Disorder ... and caregivers of patients with Attention deficit Hyperactivity Disorder (ADHD), as well as adults ... M.D., director of the Adult Attention deficit Disorder Center of Maryland and assistant ...

BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results

... 1,261,211 Liabilities and Stockholders' deficit Current liabilities: Accounts payable and ... 1,092,925 4,751,447 Accumulated deficit (11,437,876) ... - (625,774) Total stockholders' deficit (1,387,399) (6,735,658) ...

Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million

... minority interest in a subsidiary's deficit (640,744) (893,134) (1,343,184) ... Minority interest in a subsidiary's deficit 9,723 750 25,968 ... reserve (224,764) (307,053) deficit accumulated (12,391,738) ...

SemBioSys announces second quarter 2008 financial and operational results

... debenture 1,427,127 - deficit ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (3,225,371) (11,431,911) (6,453,782) deficit - Beginning of period (61,176,218) ...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... (lisdexamfetamine dimesylate) - Attention deficit and Hyperactivity Disorder ("ADHD") - On ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... (lisdexamfetamine dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

Bioheart, Inc. Announces Financial Results for Second Quarter 2008

... LIABILITIES AND SHAREHOLDERS' deficit Current liabilities Accounts payable ... Commitments and contingencies Shareholders' deficit Preferred stock ($0.001 par value) 5,000,000 ... 79,835,158 77,061,296 deficit accumulated during the development stage ...

Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)

... patients with tools and resources about Attention deficit Hyperactivity Disorder (ADHD). The newly enhanced ... and CEO of the national Attention deficit Disorder Association (ADDA), psychologist and ... 20th annual Children and Adults with Attention deficit Hyperactivity Disorder (CHADD) international ...

Galaxy Nutritional Foods Reports FY2008 Results

... $ 4,364,618 LIABILITIES AND STOCKHOLDERS' deficit CURRENT LIABILITIES: Secured borrowings ... 70,167,149 70,167,149 Accumulated deficit (70,970,948) (72,309,803) Total stockholders' deficit (632,699) (1,971,554) ...

Advance Nanotech Reports First Quarter 2008 Financial Results

... 7,187,471 6,854,191 STOCKHOLDERS' deficit Preferred stock; $0.001 par value; 25,000,000 ... loss (1,372,437) (801,386) deficit accumulated during development stage ... (31,911,750) (30,826,109) TOTAL STOCKHOLDERS' deficit (15,829,177) (12,753,808) ...

Bioheart, Inc. Announces Financial Results for First Quarter 2008

... LIABILITIES AND SHAREHOLDERS' deficit Current liabilities Accounts payable ... Commitments and contingencies Shareholders' deficit Preferred stock ($0.001 par value) ... 78,720,440 77,061,296 deficit accumulated during the development stage ...

Vermillion Announces First Quarter 2008 Financial Results and Business Progress

... $24,053 Liabilities and Stockholders' deficit Current liabilities: Accounts payable ... 228,067 227,895 Accumulated deficit (243,988) ... (640) (221) Total stockholders' deficit (16,555) (11,462) ...

Shire Launches Nationwide Adult ADHD Mobile Awareness Tour

... screening initiative for adults with Attention deficit Hyperactivity Disorder (ADHD), a ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

SemBioSys announces first quarter 2008 financial and operational results

... 7,506,865 7,326,962 deficit (61,176,218) ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (5,017,055) (3,228,411) deficit - Beginning of period (56,159,163) ...

Publication of Supplementary Prospectus

... Application for use in the treatment of Attention deficit Hyperactivity Disorder in adults, which was ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

... Product Highlights VYVANSE(TM) - Attention deficit and Hyperactivity Disorder ("ADHD") - By April ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults

... of Medicine and director of the Adult Attention deficit Disorder Center of Maryland. "The good news is ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million

... Loss before minority interest in a subsidiary's deficit (2,893,027) (2,541,502) Minority interest in a subsidiary's deficit (332) ... reserve (307,053) (523,468) deficit accumulated (11,074,522) ...

SemBioSys announces 2007 financial and operational results

... 7,326,962 5,475,404 deficit ... Statements of Loss, Comprehensive Loss and deficit For the years ended December 31, ... loss for the year (15,418,677) (14,127,086) deficit - Beginning of year ...

NPS Pharmaceuticals Reports 2007 Financial Results

... (2,504) (1,892) Accumulated deficit (869,529) (868,872) Total stockholders' deficit (188,031) (193,244) Total liabilities and stockholders' deficit $231,757 $224,740 * Non-recourse debt ...

Spectral announces 2007 financial results

... 5,606 5,489 deficit ... of Operations, Comprehensive (Loss) Income and deficit ... (1,666) 3,730 deficit - Beginning of period ...

Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones

... Liabilities and Stockholders' deficit Current liabilities: Accounts payable ... 227,895 207,991 Accumulated deficit (239,142) ... (221) (71) Total stockholders' deficit (11,462) (9,901) ...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

... Product Highlights - VYVANSE(TM) - Attention deficit and Hyperactivity Disorder ("ADHD"). - Approved ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients

... additional dosage strengths for the attention deficit hyperactivity disorder (ADHD) treatment, ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... dimesylate) (Attention deficit and Hyperactivity Disorder ("ADHD")); the impact ...

NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance

... (500) (1,892) Accumulated deficit (890,734) (868,872) Net stockholders' deficit (209,698) (193,244) Total liabilities and stockholders' deficit $361,489 $224,740 About NPS ...

SemBioSys announces 2007 third quarter results

... 6,026,443 5,475,404 deficit ... Statements of Loss, Comprehensive Loss and deficit (Unaudited) ... (2,659,025) (10,134,732) (9,771,546) deficit - Beginning of period (47,194,268) ...

Shire Divests Non-Core Product Portfolio to Almirall

... Shire's focus is on building its attention deficit hyperactivity disorder (ADHD), human genetic ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... to the impact of those on Shire's Attention deficit and Hyperactivity Disorder (ADHD) franchise; ...

Celebrity Designer Ty Pennington to Host 'ADHD Experts on Call' Program

... ADHD Experts to Answer Questions about Attention deficit Hyperactivity Disorder ... Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic ... to the impact of those on Shire's Attention deficit and Hyperactivity Disorder ("ADHD") franchise; ...

WuXi PharmaTech Announces Second Quarter 2007 Results

... Liabilities, mezzanine equity and shareholders' deficit Current liabilities: Short-term bank ... (360) (360) Total shareholders' deficit (33,492) (928) ... mezzanine equity and shareholders' deficit 151,886 85,691 Note 1: Eight ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... senior notes 130,471 155,084 Stockholders' deficit (80,642) (110,371) ... -------- Total liabilities and stockholders' deficit $165,647 $171,810 ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... liabilities 4,849 4,933 Stockholders' deficit (297,044) (299,873) ... Total liabilities and stockholders' deficit $ 382,320 $ 385,197 ...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... 64,243 Convertible debt 66,391 142,373 Accumulated deficit (1,352,870) (1,312,320) Total deficit (57,630) (132,061) (1) Amounts reflect a one-for-ten ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... to assess the efficacy and safety of VYVANSE in non ADHD ("Attention deficit Hyperactivity Disorder") indications. Our HGT pipeline has been ... comprehensive income 119.7 97.0 Accumulated deficit (843.8) (1,051.7) Total Shire plc ...

Vasogen Announces Second Quarter 2009 Results

... surplus 24,121 23,555 deficit (401,193) (397,857) ... STAGE COMPANY) Interim Consolidated Statements of Operations, deficit and Comprehensive Income (In thousands of Canadian dollars, except ...
Other Contentsskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalmoldsmoldsmoldsmoldsmoldsmoldsslimeslimeintestineintestineintestineintestineintestineintestinesmallsmallsmallsmallsmallsmallsmallsmallsmallsmallsmoothsmoothsmoothsmoothsmoothsmoothsmoothsmoothhybridizationhybridizationhybridizationhybridizationhybridizationhybridizationhybridizationhybridization
(Date:11/4/2009)...t, hold the power to help militaries and munitions...xic waste on test sites. , Compounds known as ni...World War II and have been used in military muniti...often used to propel tank shells and act like a mo...ed knowledge of their environmentally harmful effe...
(Date:11/4/2009)...re/ -- DigitalPersona, Inc., a leader in fingerpri...nounced that WAND Corporation, a leading supplier ...restaurants, has integrated DigitalPersona technol...ns. WAND,s quick-service customers can now use fin...y and deter unauthorized manager overrides. As a...
(Date:11/4/2009)...l Rainmakers, Inc., an intellectual property holdi...announced that the company has exited its "stealth...ts suite of technologies designed to leverage cutt...g the past four years, the company has spent tens ...ies of core--but expandable--technologies built ar...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3People vary widely in ability to eliminate arsenic from the body 55403 1UCF discovery could open door to obesity diabetes treatments 9700 1UCF discovery could open door to obesity diabetes treatments 9700 2Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 2
(Date:11/8/2009)..., Higher Costs and Crushing Taxes Nail Nation...re-USNewswire/ -- In response to U.S. House passag...ess & Entrepreneurship Council (SBE Council) p...wing statement: ,, "Make no mistake, those vot... creators with higher costs and crushing taxes and...
(Date:11/8/2009)..., Freeze-drying of biopha...s Mississauga, Ontario facility. , ... Thomas Wellner, President and CEO of Therapure Bi...taken delivery of a commercial scale pharmaceutica...l scale freeze drying (lyophilization) available f...
(Date:11/8/2009)..., Nation,s largest network of Hispanic healt...th care reform in 2009 ,, WASHINGTON, Nov. 7 /...of Representatives showed they have heard the voic...Health Care for America Act. Now the Senate must d...l health care reform," said Dr. Jane L. Delgado, P...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care ...engthen Medicare, improve coverage for all America...-- Today, the United States House of Representativ...re reform legislation that would strengthen Medica... companies that prices millions of Americans out o...
(Date:11/7/2009)..., WASHINGTON , Nov. 7 /PRNewswire-USNewswir...or today in support of H.R. 3962, the Affordable H...n the legislation later tonight. Below are the Sp...we all know, is an historic moment for our nation ...leaders of every party and political philosophy --...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
Other TagsLizardIntensiveGeorgiaPartsExposureExposureIntimateWoundWoundMovementMovementAdvancedAdvancedAdvancedAdvancedAdvancedAustralianOther Tagsaccording 2according 3according 4according 5according 6according 7according 8according 9according 10olds 2olds 3peaks 2biopsies 2